GRTS Gritstone Oncology, Inc. Stock Quote

GRTS [NASD]

Index	-	P/E	-	EPS (ttm)	-2.87	Insider Own	0.30%	Shs Outstand	37.75M	Perf Week	-7.44%
Market Cap	554.74M	Forward P/E	-	EPS next Y	-2.35	Insider Trans	-	Shs Float	37.75M	Perf Month	-21.56%
Income	-105.90M	PEG	-	EPS next Q	-0.61	Inst Own	77.60%	Short Float	7.53%	Perf Quarter	352.33%
Sales	3.60M	P/S	154.09	EPS this Y	-26.80%	Inst Trans	43.60%	Short Ratio	0.90	Perf Half Y	320.12%
Book/sh	1.91	P/B	7.10	EPS next Y	12.00%	ROA	-68.80%	Target Price	21.00	Perf Year	60.21%
Cash/sh	1.72	P/C	7.87	EPS next 5Y	-	ROE	-101.30%	52W Range	2.54 - 35.20	Perf YTD	244.42%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-72.90%	52W High	-61.45%	Beta	-
Dividend %	-	Quick Ratio	3.40	Sales past 5Y	-	Gross Margin	-	52W Low	435.31%	ATR	2.52
Employees	177	Current Ratio	3.40	Sales Q/Q	-10.00%	Oper. Margin	-	RSI (14)	46.59	Volatility	9.80% 9.67%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	10.50%	Profit Margin	-	Rel Volume	0.15	Prev Close	13.27
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	3.17M	Price	13.57
Recom	2.00	SMA20	-12.01%	SMA50	18.60%	SMA200	128.53%	Volume	486,375	Change	2.26%

Jan-20-21

Downgrade

Robert W. Baird

Outperform → Underperform

Jul-26-19

Initiated

Robert W. Baird

Outperform

$17

Mar-15-19

Initiated

Raymond James

Outperform

Mar-07-19

Initiated

H.C. Wainwright

Buy

$17

Oct-23-18

Initiated

Goldman

Neutral

$18

Oct-23-18

Initiated

BTIG Research

Buy

$26

Feb-11-21 06:55AM	4 Top COVID Stocks to Buy in February Motley Fool
Feb-01-21 04:21PM	Biotech Stock Gritstone Stumbles On Gilead Tie-Up, While Arcus Pops Investor's Business Daily -5.52%
06:17AM	Gritstone Oncology shares soar 44% premarket on news of collaboration with Gilead to develop HIV therapy MarketWatch
06:00AM	Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstones Vaccine Platform Technology for HIV Cure Business Wire
04:10AM	Gritstone Spikes on Gilead Partnership to Develop HIV Vaccine TheStreet.com
Jan-27-21 08:19AM	Moving Average Crossover Alert: Gritstone Oncology (GRTS) Zacks -15.86%
Jan-23-21 06:14AM	Is This Under-the-Radar COVID Stock the Next Moderna? Motley Fool
Jan-21-21 08:16AM	Trade Carefully With Soaring Gritstone Oncology TheStreet.com
08:05AM	The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga
Jan-20-21 07:33PM	Gritstones Unique Approach Can Set Its 2nd Gen COVID-19 Vaccine Apart, Says Analyst TipRanks +14.46%
04:34PM	Gritstone Touches Record, Defying Analysts Double Downgrade Bloomberg
04:13PM	Pfizer Says Covid Jab Could Battle U.K. Variant; Gritstone Expands Its Gain Investor's Business Daily
12:13PM	Biotech Stock Roundup: ALXN Pauses Study, ACRS & GRTS Surge, & Other Updates Zacks
09:25AM	Gritstone (GRTS) to Begin Coronavirus Vaccine Study, Stock Up Zacks
08:00AM	Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine GlobeNewswire
Jan-19-21 03:27PM	Gritstone Soars Due to Progress on COVID Vaccine TheStreet.com +248.51%
06:00AM	Gritstone Advances Second Generation COVID-19 Vaccine CORAL Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2 GlobeNewswire
Jan-11-21 08:00AM	Gritstone Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire +9.25%
Dec-28-20 08:00AM	Gritstone Oncology Announces Private Placement Financings Totaling $125 Million GlobeNewswire -12.32%
Dec-23-20 08:33AM	Gritstone Oncology Announces $110 Million Private Placement GlobeNewswire +24.55%
Dec-04-20 10:15AM	Here is What Hedge Funds Think About Gritstone Oncology, Inc. (GRTS) Insider Monkey
Nov-05-20 09:01AM	Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights GlobeNewswire
Nov-02-20 08:00AM	Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATE GlobeNewswire
Sep-21-20 09:27AM	Can Gritstone Oncology (NASDAQ:GRTS) Afford To Invest In Growth? Simply Wall St. -8.79%
Sep-15-20 08:00AM	Gritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare Conference GlobeNewswire
Sep-08-20 08:00AM	Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September GlobeNewswire +5.92%
Aug-06-20 05:19PM	3 Strong Buy Healthcare Stocks Under $5 That Could See Outsized Gains TipRanks
Aug-05-20 10:25AM	Gritstone Oncology, Inc. (GRTS) Reports Q2 Loss, Misses Revenue Estimates Zacks
09:01AM	Gritstone Oncology Reports Second Quarter Financial Results and Recent Highlights GlobeNewswire
Aug-03-20 12:31PM	Analysts Estimate Gritstone Oncology, Inc. (GRTS) to Report a Decline in Earnings: What to Look Out for Zacks
08:00AM	Gritstone Oncology to Present at Two Upcoming Investor Conferences in August GlobeNewswire
Jul-22-20 02:28PM	Do Institutions Own Gritstone Oncology, Inc. (NASDAQ:GRTS) Shares? Simply Wall St.
Jun-24-20 08:00AM	Gritstone Oncology to Present Clinical Data from Ongoing GRANITE and SLATE Phase 1 Studies During Investor Webcast on July 13 GlobeNewswire
Jun-14-20 08:59PM	Hedge Funds Are Done Selling Gritstone Oncology, Inc. (GRTS) Insider Monkey
Jun-10-20 08:00AM	Gritstone Oncology Announces the Addition of Jean-Charles Soria, M.D., Ph.D., to its Scientific Advisory Board GlobeNewswire
Jun-04-20 08:00AM	Gritstone Oncology to Present at Two Upcoming Investor Conferences in June GlobeNewswire
May-22-20 09:15AM	Gritstone Oncology (GRTS): Strong Industry, Solid Earnings Estimate Revisions Zacks +5.16%
May-10-20 10:14AM	Analysts Have Made A Financial Statement On Gritstone Oncology, Inc.'s (NASDAQ:GRTS) First-Quarter Report Simply Wall St.
May-07-20 11:15AM	Gritstone Oncology Inc (GRTS) Reports Q1 Loss, Tops Revenue Estimates Zacks
09:01AM	Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights GlobeNewswire
May-01-20 08:00AM	Gritstone Oncology Announces the Appointment of Dr. Elaine V. Jones as Chair of the Board of Directors GlobeNewswire -9.99%
Apr-06-20 08:00AM	Gritstone Oncology Announces the Appointment of Veteran Legal Executive Rahsaan Thompson as General Counsel GlobeNewswire +9.02%
Mar-13-20 08:30AM	Earnings Update: Gritstone Oncology, Inc. Just Reported And Analysts Are Boosting Their Estimates Simply Wall St. +9.75%
Mar-11-20 10:25AM	Gritstone Oncology, Inc. (GRTS) Reports Q4 Loss, Misses Revenue Estimates Zacks -5.26%
09:01AM	Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights GlobeNewswire
Feb-25-20 04:00PM	Gritstone Oncology to Present at Two Investor Conferences in March GlobeNewswire
12:09PM	Analysts: 3 Healthcare Stocks to Buy on Coronavirus Weakness TipRanks
Jan-08-20 04:00PM	Gritstone Oncology to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-01-20 11:27AM	We Think Gritstone Oncology (NASDAQ:GRTS) Needs To Drive Business Growth Carefully Simply Wall St.
Dec-16-19 07:36AM	Is Gritstone Oncology, Inc. (GRTS) A Good Stock To Buy? Insider Monkey -11.63%
Dec-12-19 07:38AM	The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win Benzinga -11.37%
05:05AM	Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE GlobeNewswire
Dec-09-19 08:00AM	Gritstone Oncology to Webcast a Review of the Clinical Immunogenicity Data from its Neoantigen-based Immunotherapies that will be Presented at the ESMO Immuno-Oncology Congress GlobeNewswire
Nov-26-19 08:00AM	Gritstone Oncology to Present at the Piper Jaffray Annual Healthcare Conference GlobeNewswire -5.33%
Nov-12-19 10:15AM	Gritstone Oncology, Inc. (GRTS) Reports Q3 Loss, Misses Revenue Estimates Zacks
09:01AM	Gritstone Oncology Reports Third Quarter 2019 Financial Results and Recent Highlights GlobeNewswire
Nov-06-19 10:30AM	Will Gritstone Oncology, Inc. (GRTS) Report Negative Q3 Earnings? What You Should Know Zacks
Nov-05-19 08:05AM	Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy GlobeNewswire
Oct-31-19 08:00AM	Gritstone Oncology to Webcast Investor Event Reviewing its Neoantigen-based Immunotherapies During SITC Conference GlobeNewswire +5.87%
Oct-07-19 08:00AM	Gritstone Oncology Announces Upcoming Presentation on Novel Shared Neoantigens Included within Off-The-Shelf SLATE Immunotherapy at SITC 2019 Annual Meeting GlobeNewswire
Sep-27-19 08:22AM	Investors Who Bought Gritstone Oncology (NASDAQ:GRTS) Shares A Year Ago Are Now Down 37% Simply Wall St. -5.59%
Sep-26-19 08:00AM	Gritstone Oncology to Present at Cantor Global Healthcare Conference GlobeNewswire
Sep-12-19 08:00AM	Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. Jones GlobeNewswire -6.85%
Aug-14-19 03:40PM	Its not just Bloom Energy: Half of last years Bay Area IPO stocks are underwater American City Business Journals
08:00AM	Gritstone Oncology Announces First Patient Dosed with SLATE, its Off-The-Shelf Neoantigen Immunotherapy GlobeNewswire
Aug-12-19 09:01AM	Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights GlobeNewswire
Jul-08-19 08:00AM	Gritstone Oncology Announces the Appointment of Dr. Vijay Yabannavar, a Biopharma Leader with Over 30 Years of Experience, as Executive Vice President of Manufacturing and Technical Operations GlobeNewswire
Jun-05-19 08:00AM	Gritstone Oncology to Present at Two Upcoming Investor Conferences in June GlobeNewswire
Jun-03-19 11:00AM	Health Care Digest: Why California biotech thrives, small company looks to crash NASH bash, meeting up at BIO American City Business Journals
May-30-19 08:00AM	Gritstone Oncology to Host Event with Oncology Key Opinion Leaders Discussing Neoantigen-based Immunotherapy During ASCO Annual Meeting GlobeNewswire
May-27-19 07:39AM	Could Gritstone Oncology, Inc.'s (NASDAQ:GRTS) Investor Composition Influence The Stock Price? Simply Wall St.
May-13-19 09:01AM	Gritstone Oncology Reports First Quarter 2019 Financial Results and Recent Highlights GlobeNewswire
May-09-19 08:56PM	Heres What Hedge Funds Think About Gritstone Oncology, Inc. (GRTS) Insider Monkey
Apr-25-19 11:42AM	Why Gritstone Oncology Stock Is Sinking Today Motley Fool -12.93%
07:58AM	The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings Benzinga
Apr-24-19 08:53PM	Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock GlobeNewswire -5.02%
Apr-23-19 08:08AM	The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale Benzinga -11.00%
Apr-22-19 04:28PM	Gritstone Oncology Announces Proposed Public Offering of Common Stock GlobeNewswire +5.90%
08:00AM	Gritstone Oncology Announces Clinical Acceleration of Off-The-Shelf Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback GlobeNewswire
Apr-04-19 08:00AM	Gritstone Oncology Announces the Addition of Eugene Zhukovsky, Expert in Bispecific Biotherapeutics Development, to its Scientific Advisory Board GlobeNewswire +5.13%
Apr-03-19 04:00PM	Gritstone Oncology to Present at Needham Healthcare Conference GlobeNewswire
10:02AM	After inking lease with cancer-fighting company, this new East Bay biotech project is full American City Business Journals
Apr-02-19 04:00PM	Gritstone Oncology Presents Data at AACR Demonstrating MHC Class II Neoantigen Prediction with EDGE Significantly Outperforms Current Prediction Methods GlobeNewswire +9.51%
Mar-28-19 04:00PM	Gritstone Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights GlobeNewswire +5.47%
Mar-25-19 09:19AM	Health Care Digest: Genentech's tumor-agnostic cancer drug, Novartis' East Bay option and more American City Business Journals
Mar-21-19 04:00PM	Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001 GlobeNewswire
Mar-11-19 08:00AM	Gritstone Oncology Announces the Appointment of Technology Executive, Mike Forcht, as Senior Vice President of Human Resources to Support Vision for Growth GlobeNewswire
Mar-05-19 04:00PM	Gritstone Oncology to Present at Two Upcoming Investor Conferences in March GlobeNewswire -8.10%
Feb-27-19 06:12PM	Gritstone Oncology Announces Oral Presentation on MHC Class II Antigen Prediction at the AACR Annual Meeting in April 2019 GlobeNewswire
Feb-20-19 04:00PM	Gritstone Oncology to Present at Leerink Partners Annual Global Healthcare Conference GlobeNewswire
Jan-06-19 08:00AM	Gritstone Oncology Announces Updated Presentation Time at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-03-19 06:16PM	Gritstone Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-18 10:11AM	2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma American City Business Journals
Dec-20-18 04:00PM	Gritstone Oncology Announces FDA Fast Track Designation for GRANITE-001 for the Treatment of Colorectal Cancer GlobeNewswire -17.00%
Dec-19-18 04:17PM	TCR2 Therapeutics Announces Oncology Industry Leader and Expert Andrew Allen, M.D., Ph.D. Joins its Board of Directors PR Newswire -9.32%
Dec-17-18 11:00AM	Gritstone Oncology Announces Publication in Nature Biotechnology of Neoantigen Identification Capabilities of its Artificial Intelligence Platform, EDGE GlobeNewswire -7.08%
Dec-15-18 08:03AM	3 Biotechs Gilead Sciences Could Buy in March Motley Fool
Dec-13-18 05:18PM	Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay American City Business Journals
Dec-10-18 07:00AM	Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead GlobeNewswire -11.37%
Nov-26-18 02:03PM	Here's how much better insiders have profited from this year's IPO boom American City Business Journals

Gritstone Oncology, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate which is in Phase I/II clinical study for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was founded in 2015 and is headquartered in Emeryville, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rousseau Raphael	See Remarks	Jan 20	Option Exercise	0.76	10,000	7,600	10,000	Jan 21 05:11 PM
Rousseau Raphael	See Remarks	Jan 20	Sale	25.07	10,000	250,705	0	Jan 21 05:11 PM
Rousseau Raphael	See Remarks	Jan 19	Option Exercise	0.76	20,000	15,200	20,000	Jan 21 05:11 PM
Rousseau Raphael	See Remarks	Jan 19	Sale	17.53	20,000	350,564	0	Jan 21 05:11 PM
Yelensky Roman	See Remarks	Jan 19	Sale	22.10	10,000	221,029	133,224	Jan 21 05:06 PM
Woiwode Thomas	Director	Dec 30	Buy	3.71	1,347,709	5,000,000	1,347,709	Jan 04 06:02 PM
Jones Erin	See Remarks	Aug 17	Option Exercise	0.35	10,000	3,450	20,000	Aug 19 07:05 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience